High-risk AI systems directly influence medical decisions, patient safety, and healthcare services. Some examples are AI tools that predict sepsis, help with cancer screenings, or assist in robotic surgeries.
These systems need careful handling of patient data and must work accurately to avoid mistakes. Healthcare workers also need to understand how these AI tools make decisions. Because they affect patient health so much, these AI systems must be tested carefully, assessed for risks, and monitored regularly. Regulatory rules help make sure this happens.
In the United States, there is no single law like the European Union’s AI Act. Instead, several agencies like the Food and Drug Administration (FDA), the Department of Health and Human Services (HHS), and the Office for Civil Rights (OCR) offer guidelines and controls on using AI in healthcare. As more AI tools come into hospitals, these rules will become even more important.
The European Union (EU) leads in setting detailed rules for AI. Their AI Act, which starts to apply fully by 2026 or 2027, controls high-risk AI systems like those in healthcare. Some main requirements of the AI Act are:
Even though the AI Act applies to the EU, its detailed rules provide useful ideas for the U.S. People making policies and hospital managers in the U.S. can learn from these rules since future American laws might become similar.
Healthcare leaders in the U.S. face many challenges when trying to use AI safely. Some key issues are:
Building trust among healthcare workers and patients is very important. Efforts like Explainable AI (XAI) help doctors understand how AI reaches decisions, which increases transparency and trust.
AI helps hospitals not only with clinical decisions but also by automating everyday and admin tasks. This can make work faster and reduce human mistakes. It also allows healthcare workers to spend more time with patients.
AI can forecast how many patients will come and help plan appointments, staff, and equipment use. Good forecasting helps hospitals keep beds ready, cut down waiting, and balance staff work. In Europe, the European Health Data Space (EHDS) uses secure health data to improve these decisions. The U.S. can develop similar systems for wider AI use.
AI phone systems, like those from Simbo AI, can talk with patients automatically but naturally. They can schedule appointments, answer common questions, and check basic health issues without needing a person. This lowers staff workload, makes it easier for patients to get help, and improves patient experience. AI answering machines can work all day, every day, which is good for urgent messages and helps medical offices manage communication while keeping good service.
AI tools that write down doctor-patient talks automatically save time and reduce errors in records. This helps hospitals follow rules about documents and frees doctors to spend more time with patients. Good scribing also lowers costs and improves record accuracy, which matters for billing and legal issues.
AI can automate insurance claims and billing, making them more accurate and faster. It can spot mistakes early, so fewer claims get rejected. Medical managers who handle money find AI tools useful for smoother operations.
Healthcare leaders and IT staff in the U.S. should follow these steps to meet regulations and use AI well:
Healthcare office managers and IT workers in the U.S. must bring in AI tools carefully while obeying healthcare laws. They pick AI systems that help meet goals like better patient care, more efficiency, and lower costs. They also protect patient data and support doctors’ work.
AI automates front-office jobs such as scheduling and call handling. This cuts down administrative work and lets staff focus more on patients and complex tasks. In clinics, AI decision support must fit well with existing EHR systems to avoid problems or isolated data.
Training staff on AI tools, cybersecurity, and rules helps hospitals handle technology and regulatory risks better. IT staff use AI monitoring tools to watch system health, spot odd activity, and act quickly when needed.
The U.S. does not yet have one big AI law like the EU’s AI Act, but it is working on rules for high-risk AI. The FDA is updating how it regulates AI with programs like:
Hospitals in the U.S. can look at examples like the AI Act to get ready for future rules about transparency, responsibility, and human control.
AI can help improve healthcare and make hospital work faster and better. But AI must be used safely and reliably. This needs strong rules and careful work by hospitals.
High-risk AI needs close checks for risks, clear explanations, good data, human control, cybersecurity, and regular monitoring to stay safe and earn trust.
Healthcare managers and IT staff in the U.S. should learn about changing rules, use AI that meets high standards, fit AI smoothly into hospital work, and work well with others. Automated front-office tools and systems that help with documentation can save time and money when used properly, helping patients get better care.
As AI grows, solid rules and care by hospitals will be key to getting its benefits for both patients and those who care for them.
AI improves healthcare by enhancing resource allocation, reducing costs, automating administrative tasks, improving diagnostic accuracy, enabling personalized treatments, and accelerating drug development, leading to more effective, accessible, and economically sustainable care.
AI automates and streamlines medical scribing by accurately transcribing physician-patient interactions, reducing documentation time, minimizing errors, and allowing healthcare providers to focus more on patient care and clinical decision-making.
Challenges include securing high-quality health data, legal and regulatory barriers, technical integration with clinical workflows, ensuring safety and trustworthiness, sustainable financing, overcoming organizational resistance, and managing ethical and social concerns.
The AI Act establishes requirements for high-risk AI systems in medicine, such as risk mitigation, data quality, transparency, and human oversight, aiming to ensure safe, trustworthy, and responsible AI development and deployment across the EU.
EHDS enables secure secondary use of electronic health data for research and AI algorithm training, fostering innovation while ensuring data protection, fairness, patient control, and equitable AI applications in healthcare across the EU.
The Directive classifies software including AI as a product, applying no-fault liability on manufacturers and ensuring victims can claim compensation for harm caused by defective AI products, enhancing patient safety and legal clarity.
Examples include early detection of sepsis in ICU using predictive algorithms, AI-powered breast cancer detection in mammography surpassing human accuracy, and AI optimizing patient scheduling and workflow automation.
Initiatives like AICare@EU focus on overcoming barriers to AI deployment, alongside funding calls (EU4Health), the SHAIPED project for AI model validation using EHDS data, and international cooperation with WHO, OECD, G7, and G20 for policy alignment.
AI accelerates drug discovery by identifying targets, optimizes drug design and dosing, assists clinical trials through patient stratification and simulations, enhances manufacturing quality control, and streamlines regulatory submissions and safety monitoring.
Trust is essential for acceptance and adoption of AI; it is fostered through transparent AI systems, clear regulations (AI Act), data protection measures (GDPR, EHDS), robust safety testing, human oversight, and effective legal frameworks protecting patients and providers.